Oxidative biotransformation of 2-acetylaminofluorene in fetal and placental tissues of humans and monkeys. Correlations with aryl hydrocarbon hydroxylase activities
- PMID: 1224
Oxidative biotransformation of 2-acetylaminofluorene in fetal and placental tissues of humans and monkeys. Correlations with aryl hydrocarbon hydroxylase activities
Abstract
The mixed-function oxidation of 14C-labled 2-acetylaminofluorene (AAF) was investigated in placental and fetal tissues of humans and monkeys (Macaca nemestrina) in vitro. The major metabolite formed in most tissues was 7-hydroxy-AAF. Rates of the hydroxylation reactions varied widely among the tissues investigated and were generally one to two orders of magnitude lower than those measured in rat hepatic tissues. High correlations among rates of 7-,5-, and 3- and between 1- and N-hydroxylations of AAF were observed. The latter two reactions were less responsive to inhibition by carbon monoxide. Rates of 3-hydroxylations of benzo[a]pyrene (BP) also were highly correlated with rates of 7-, 5-, and 3-hydroxylations of AAF but were not correlated with rates of 1- and N-hydroxylations in human placental microsomes. A lack of statistically significant correlations was observed among rates of many of these hydroxylation reactions studied in primate fetal tissues. Rates of 7-, 5-, and 3-hydroxylations of AAF were not statistically correlated with rates of 3-hydroxylation of BP in homogenates of primate fetal tissues in most instances, but statistically significant correlations among rates of 3-hydroxylation of BP and 1- and N-hydroxylations of AAF were observed in those preparations. The results suggested two separate mechanisms for the genetic control of rates of placental aromatic ring- and N-hydroxylation reactions as opposed to apparent multiple genetic controls for rates of these hydroxylation reactions in primate fetal tissues.
Similar articles
-
Mono-oxygenase induction in the human placenta. Interrelationships among position-specific hydroxylations of 17 beta-estradiol and benzo[a]pyrene.Drug Metab Dispos. 1982 May-Jun;10(3):220-4. Drug Metab Dispos. 1982. PMID: 6125353
-
Relationship between oxidative metabolism of 2-acetylaminofluorene, debrisoquine, bufuralol, and aldrin in human liver microsomes.Cancer Res. 1984 Dec;44(12 Pt 1):5692-7. Cancer Res. 1984. PMID: 6498831
-
Cytochrome P-450-dependent biotransformation of 2-acetylaminofluorene in cell-free preparations of human embryonic hepatic, adrenal, renal, pulmonary, and cardiac tissues.Drug Metab Dispos. 1994 Mar-Apr;22(2):331-7. Drug Metab Dispos. 1994. PMID: 8013290
-
Xenobiotic metabolism in the maternal-placental-fetal unit: implications for fetal toxicity.Dev Pharmacol Ther. 1984;7 Suppl 1:11-7. doi: 10.1159/000457221. Dev Pharmacol Ther. 1984. PMID: 6394251 Review. No abstract available.
-
Drug biotransformation in the placenta.Pharmacol Ther. 1980;8(3):501-24. doi: 10.1016/0163-7258(80)90074-1. Pharmacol Ther. 1980. PMID: 6992160 Review. No abstract available.
Cited by
-
Drug metabolism by the human fetus.Clin Pharmacokinet. 1980 Jul-Aug;5(4):320-39. doi: 10.2165/00003088-198005040-00002. Clin Pharmacokinet. 1980. PMID: 6994979 Review.